Synthesis of silver nanoparticles using fungi
US-9701552-B1 · Jul 11, 2017 · US
US12220430B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12220430-B2 |
| Application number | US-202318301505-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 17, 2023 |
| Priority date | Apr 15, 2021 |
| Publication date | Feb 11, 2025 |
| Grant date | Feb 11, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Silver and titanium oxide nanoparticles produced with Fomes fomentarius or Fomitopsis pinicola aqueous extracts and methods for treating bacterial infections or cancer using them.
Opening claim text (preview).
The invention claimed is: 1. A method of making TiO 2 nanoparticles, comprising: drying a Fomitopsis pinicola sample to form a F. pinicola powder, mixing the F. pinicola powder with water to form a F. pinicola precursor, sonicating the F. pinicola precursor then centrifuging to obtain a F. pinicola extract; reacting the F. pinicola extract with titanium isopropoxide to form the TiO 2 nanoparticles; and isolating and drying the TiO 2 nanoparticles, wherein upon contacting the TiO 2 nanoparticles with colorectal cancer cells a cell viability of the colorectal cancer cells is reduced to 20% of a cell viability of a control group of colorectal cancer cells not contacted with the TiO 2 nanoparticles, wherein an amount of the TiO 2 nanoparticles in the contacting with the colorectal cancer cells is 0.5 μg per milliliter of a cell culture of the colorectal cancer cells, wherein upon contacting the TiO 2 nanoparticles with the colorectal cancer cells a cell nuclei of the colorectal cancer cells undergo nuclear condensation thereby killing a majority of the colorectal cancer cells, wherein the TiO 2 nanoparticles contain components of the F. pinicola as evident by Fourier transform infrared (FT-IR) spectroscopy absorption peaks at 1414 cm −1 , and 1000 cm −1 corresponding to aliphatic C—N, and aromatic C═N bands, respectively, wherein the TiO 2 nanoparticles have a further FT-IR spectroscopy absorption peak at 3439 cm −1 corresponding to —OH, and wherein the TiO 2 nanoparticles have a broadest dimension ranging from 80 to 120 nm. 2. The method of claim 1 , wherein the TiO 2 nanoparticles are agglomerated. 3. The method of claim 1 , wherein the TiO 2 nanoparticles are in a rutile phase and an anatase phase. 4. The method of claim 1 , wherein in the reacting a ratio of the F. pinicola extract to the titanium isopropoxide by volume is 1:10, and wherein the titanium isopropoxide has a 1 millimolar concentration in water. 5. The method of claim 4 , wherein the colorectal cancer cells are HCT-116 cells.
Basidiomycota, e.g. Cryptococcus · CPC title
Silver; Compounds thereof · CPC title
Oxides; Hydroxides · CPC title
Nanocapsules; {Nanoparticles; (nanotubes A61K9/0092; polymeric micelles A61K9/1075; polymersomes A61K9/1273; pure drug nanoparticles A61K9/14; drug nanoparticles with adsorbed surface modifiers A61K9/141; conjugates, e.g. between drug and non-active nanoparticles, A61K47/50; preparations for in vivo diagnosis A61K49/00; with radioactive substances A61K51/00)} · CPC title
Processes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.